| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3944888 | Gynecologic Oncology | 2007 | 5 Pages |
Abstract
Preoperative CA125 elevation is a marker of extrauterine disease and deep myometrial invasion in patients with uterine CS. Postoperative CA125 elevation is an independent prognostic factor for poor survival. These findings indicate that CA125 may be a clinically useful serum marker in the management of patients with CS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Gloria S. Huang, Lydia G. Chiu, Juliana S. Gebb, Marc J. Gunter, Paniti Sukumvanich, Gary L. Goldberg, Mark H. Einstein,